Author Question: How should a nongovernment not-for-profit organization generally report increases in the fair value ... (Read 91 times)

jhjkgdfhk

  • Hero Member
  • *****
  • Posts: 569
How should a nongovernment not-for-profit organization generally report increases in the fair value of marketable debt securities in its statement of activities?
 
  A. Such increases in fair value should not be reported because debt securities are reported at amortized cost.
  B. As an increase in restricted net assets
  C. As an increase in temporarily restricted net assets
  D. As an increase in unrestricted net assets, unless restricted by donor stipulation or law

Question 2

A(n) ___________________ ___________ is designed to collect, process, and report information related to financial transactions.
 Fill in the blank(s) with correct word



jlaineee

  • Sr. Member
  • ****
  • Posts: 380
Answer to Question 1

D

Answer to Question 2

accounting information system (AIS)
accounting information system
AIS



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library